DaeHeung IBN
Adopting Sustainable Packaging Through Eco-Friendly Plastic

In a world saturated with plastic, the environmental toll of its ubiquitous use cannot be ignored. DaeHeung IBN recognizes the urgency of this crisis. As a manufacturer of pharmaceutical plastic packaging containers, Daeheung IBN focuses on sustainable green pharmaceutical packaging solutions for SDGs implementation, plastic conversion into petrochemicals, preservation of marine and terrestrial ecosystems, and realization of ESG values.

“The outburst of the pandemic has amplified the prominence of pharmaceutical products, leading the industry to transform its packaging practices. DaeHeung IBN confronts this challenge by specializing in eco-friendly plastic products,” says Jae-woo, Jung, senior executive director, DaeHeung IBN. “Our mission is to disseminate information about reducing plastic waste in the pharmaceutical sector, offering insights into hazardous chemicals, plastic substitutes, and alternatives for plastic polymers and products.”

Its premier product, ‘Eco UCOV,’ exemplifies its dedication to sustainable packaging. This innovative container, developed using GEX, a second-generation natural polymer derived from eggshells, contributes to a 30 percent reduction in plastic usage, a significant step towards a plastic-free and resource-circulating future.

Envisioning a greener future, the Eco UCOV comes with a certification of SGS (Société Générale de Surveillance) Eco-product, making it environmentally beneficial. Compared to traditional petroleum-derived materials like high-density polyethylene (HDPE), GEX significantly reduces the carbon footprint. The SGS test reports released in November 2021 stated that the product gave positive outcomes within the method detection limit for harmful heavy metals, total metals, flame retardants, chlorinated paraffin, and organotin compounds. These tests ensure that its products align with global policy trends and consumer demands for pharmaceutical products.

DaeHeung IBN adopts state-of-the-art technology and applies rigorous quality and hygiene standards during its production in modern and classified conditions.

It is recognized for producing products with exceptional finishing and safety features. The product’s safety and quality are ensured by making them in clean rooms suitable for producing pharmaceutical plastic packaging containers, with an ISO15378 certification, a specific requirement for applying GMP (Good Manufacturing Practice), and ISO9001 for primary pharmaceutical packaging materials. In addition, all products have passed the U.S. Pharmacopoeia USP42-NF-37<671> pharmaceutical packaging container light transmission test.

The company has also received an AA+ on GRP (Guidelines for Reducing Plastic Waste & Sustainable Ocean and Climate Action Acceleration) for developing plastic pharmaceutical containers utilizing biomass from egg shells that are considered farm waste.

DaeHeung IBN ensures the medicines are distributed in its safe packaging containers registered under the U.S. FDA DMF pharmaceutical packaging material section. It operates more efficiently and systematically through ERP, MES, and POP solutions to improve competitiveness and pursue customer satisfaction across all management fronts, including quality, purchasing, production, sales, and inventory. Introducing AI non-electrical inspection has further reduced the customer defect rate by more than 90 percent, enabling an enriched customer experience.

Our mission is to disseminate information about reducing plastic waste in the pharmaceutical sector, offering insights into hazardous chemicals, plastic substitutes, and alternatives for plastic polymers and products

The company strongly emphasizes maintaining consistent standards through its cross-check system, where employees focus on quality management through regular process inspections to ensure defect prevention and improvement via statistical process control and standardized management practices.

The massive global success of DaeHeung IBN has received numerous awards and recognition for its innovative products and commitment to sustainability. Its major client list comprises leading global pharmaceutical companies.

Daeheung IBN is official partner of Association for Supporting SDGs for the United Nations [ASD]. The Association for Supporting the SDGs for the UN (ASD) is an international nongovernmental organization that holds special consultative status to the Economic and Social Council (ECOSOC). DaeHeung IBN firmly supports the UN SDGs and strives to lead the way in climate response by encouraging industry enthusiasts to embrace a green environment. It opts for a holistic approach to sustainable management through quality teamwork, consistent improvements, and systematic problem-solving.

Prioritizing environmental awareness, the company goes beyond pharmaceutical packaging and paves a path for biodegradable practices through innovative solutions and unwavering dedication. DaeHeung IBN is a driving force in the global pursuit of eco-friendly plastic packaging and aims to carry forward its legacy by contributing to health and well-being through its specialty plastic products.